Respiratory syncytial virus market.
Storey
Shane
S
D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000191:economics / Q000276:immunology / Q000627:therapeutic use; D000998:Antiviral Agents / Q000191:economics / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003132:Commerce; D015195:Drug Design; D006801:Humans; D007223:Infant; D034741:RNA, Small Interfering / Q000191:economics / Q000627:therapeutic use; D018357:Respiratory Syncytial Virus Infections / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control; D022261:Respiratory Syncytial Virus Vaccines / Q000191:economics / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D000998:Antiviral Agents; D034741:RNA, Small Interfering; D022261:Respiratory Syncytial Virus Vaccines